Chromosomal instability and bladder cancer: the UroVysionTMtest in the UroScreen study

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study

(2012) Severine Huber et al.   BJU INTERNATIONAL

Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen

(2012) Georg Johnen et al.   PLoS One

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right Catch

(2011) Lukas Bubendorf   ACTA CYTOLOGICA

Das Screening von Harnblasenkarzinomen mittels urinbasierter Tumormarker - Erfahrungen aus der Arbeitsmedizin

(2011) M. Nasterlack et al.   AKTUELLE UROLOGIE

The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines

(2011) Beate Pesch et al.   BJU INTERNATIONAL

Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria

(2011) Gabor Pajor et al.   CYTOMETRY PART A

Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder

(2010) Hans-Martin Fritsche et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

(2010) Yair Lotan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Bladder Cancer Detection Using FISH (UroVysion Assay)

(2008) Kevin C. Halling et al.   ADVANCES IN ANATOMIC PATHOLOGY

Chromosomal instability in bladder cancer

(2008) Andrea R. Florl et al.   ARCHIVES OF TOXICOLOGY

Molecular pathogenesis of bladder cancer

(2008) Margaret A. Knowles   International Journal of Clinical Oncology

Molecular markers for detection, surveillance and prognostication of bladder cancer

(2008) Olaf PJ Vrooman et al.   INTERNATIONAL JOURNAL OF UROLOGY